Holen Sie sich die Stockscreener-App
2.58
0.00%
0.00
Handel nachbörslich:
2.63
0.05
+1.94%
Finanzdaten der Cardiff Oncology Inc-Aktie (CRDF)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
31.41%
0.205
|
0.156 | 0.141 | 0.108 | 0.083 |
Operating Expenses
|
6.20%
11.14
|
10.49 | 10.96 | 12.32 | 12.13 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
6.20%
11.14
|
10.49 | 10.96 | 12.32 | 12.13 |
| Operating Income/Loss |
5.82%
-10.93
|
-10.33 | -10.82 | -12.21 | -12.05 |
| Nonoperating Income/Loss |
7.34%
0.922
|
0.995 | 1.089 | 1.058 | 0.829 |
| Income/Loss From Continuing Operations Before Tax |
31.41%
0.205
|
0.156 | 0.141 | -11.15 | -11.22 |
| Income/Loss From Continuing Operations After Tax |
7.22%
-10.01
|
-9.337 | -9.731 | -11.15 | -11.22 |
|
Net Income/Loss
|
7.22%
-10.01
|
-9.337 | -9.731 | -11.15 | -11.22 |
| Preferred Stock Dividends And Other Adjustments |
0.00%
0.006
|
0.006 | 0.006 | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
44.68
|
- | 44.68 | 44.68 | 44.68 |
| Diluted Average Shares |
44.68
|
- | 44.68 | 44.68 | 44.68 |
| Basic Earnings Per Share |
4.76%
-0.22
|
-0.21 | -0.22 | -0.25 | -0.25 |
| Diluted Earnings Per Share |
4.76%
-0.22
|
-0.21 | -0.22 | -0.25 | -0.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.00%
0.006
|
0.006 | 0.006 | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):